July 2026 Current Affairs — Part 9
Important Current Affairs for Government Exams | Energy, Healthcare, Environment & Technology
This part covers five important July 2026 current affairs topics related to geothermal energy, coal gasification, healthcare, vaccination and long-duration energy storage.
41. India Commissions First Geothermal Wells at Puga Valley
India commissioned its first and deepest twin geothermal wells at Puga Valley in Eastern Ladakh.
The wells were commissioned by the Lieutenant Governor of Ladakh and executed by the ONGC Energy Centre.
🌋 Geothermal Wells — Key Facts
- Location: Puga Valley, Eastern Ladakh
- Well depth: 1,000 metres each
- Altitude: More than 14,000 feet
- Executed by: ONGC Energy Centre
- Energy source: Heat from inside the Earth
⚙️ How Geothermal Wells Work
- Heat comes from hot rocks beneath Earth's surface.
- Water enters underground rock cracks.
- Water gets heated and turns into steam.
- Steam is used to generate electricity.
- Hot water may emerge naturally as hot springs and sulphur fumaroles.
42. National Coal Gasification Mission
India aims to achieve 100 Million Tonnes (MT) of coal gasification capacity by 2030.
The present operational or under-implementation capacity is 22.6 Million Tonnes Per Annum (MTPA).
⛏️ Coal Gasification — Key Facts
- Target: 100 MT capacity by 2030
- Current capacity: 22.6 MTPA
- Scheme approved: 13 May 2026
- Financial outlay: ₹37,500 crore
- Expected coal/lignite utilisation: About 75 MTPA
🏭 Existing Projects
- Jindal Steel Limited (JSL): 8 MTPA — Operational
- Talcher Fertilisers Limited (TFL): 2.6 MTPA — Under implementation
- 8 projects: 12 MTPA — Under implementation
43. Semaglutide 2.4 mg
The Central Drugs Standard Control Organisation (CDSCO) approved Wegovy (Semaglutide 2.4 mg) for treating MASH.
Wegovy is developed by Novo Nordisk.
💊 Semaglutide 2.4 mg — Key Facts
- Medicine: Wegovy (Semaglutide 2.4 mg)
- Developer: Novo Nordisk
- Approved by: CDSCO
- Condition: MASH
- MASH: Metabolic Dysfunction-Associated Steatohepatitis
- Significance: First injectable GLP-1 therapy approved in India for MASH
44. India Approves First Dengue Vaccine
India approved its first dengue vaccine, QDENGA (TAK-003).
The vaccine was developed by Takeda Biopharmaceuticals and approved by the Drug Controller General of India (DCGI).
🦟 QDENGA — Key Facts
- Vaccine: QDENGA (TAK-003)
- Developer: Takeda Biopharmaceuticals
- Approved by: DCGI
- Approved age group: 4 to 60 years
- Protection: All four dengue virus serotypes
45. Bondada Engineering – 100 MWh VRFB BESS Project
Bondada Engineering, in partnership with Delectrik Systems, received a Notification of Award from NTPC Renewable Energy Ltd. (NTPC REL).
The project involves an Engineering, Procurement and Construction (EPC) contract for a 100 MWh Vanadium Redox Flow Battery Energy Storage System (VRFB BESS).
🔋 VRFB BESS — Key Facts
- Capacity: 100 MWh
- Project location: Khavda Solar Park, Gujarat
- Project: VRFB BESS
- Technology partner: Delectrik Systems
- Client: NTPC Renewable Energy Ltd.
- Technology: Vanadium Redox Flow Battery
⚡ VRFB Advantages
- Operational life of over 25 years
- High safety and stable performance
- Near-zero degradation with frequent charging and discharging
- Lower operational expenditure
- Supports long-duration energy storage
📝 Part 9 Quiz
Answer all 5 questions. Your result will appear only after you submit the quiz.
Quiz Result
🎯 Part 9 Completed
Revise these five topics carefully and continue with the next part of the July 2026 Current Affairs Series.